SCHEMBL6142952

SCHEMBL6142952

CC(=O)On1c(-c2ccccc2)cc(=O)c2ccccc21

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.57
SMN1; SMN2 Q16637 4/20 0.46
KDM4E B2RXH2 3/20 0.46
ALDH1A1 P00352 3/20 0.46
NPSR1 Q6W5P4 1/20 0.46
HSD17B10 Q99714 4/20 0.40
LMNA P02545 3/20 0.40
CYP2C19 P33261 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
HIF1A Q16665 1/20 0.40
RAB9A P51151 1/20 0.39
MAPK1 P28482 1/20 0.38
POLB P06746 1/20 0.37
MAOA P21397 1/20 0.36
AGTR1 P30556 1/20 0.36
ADORA1 P30542 2/20 0.36
ADORA2A P29274 1/20 0.36
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5227447 0.81 ALDH1A1 (0.56) HPGDKDM4EALDH1A1HSD17B10MAOA
SCHEMBL1906715 0.76 POLB (0.55) HPGDSMN1; SMN2KDM4EALDH1A1HSD17B10
Acetic Acid SCHEMBL27642498 0.75 HPGD (0.59) HPGDSMN1; SMN2KDM4EALDH1A1NPSR1
SCHEMBL3373253 0.75 P2RX4 (0.47) HPGDSMN1; SMN2KDM4EALDH1A1HSD17B10
SCHEMBL9386193 0.73 HPGD (1.00) HPGDSMN1; SMN2KDM4EALDH1A1NPSR1
SCHEMBL25327891 0.72 HPGD (0.55) HPGDSMN1; SMN2KDM4EALDH1A1NPSR1
SCHEMBL28852105 0.70 HPGD (0.65) HPGDSMN1; SMN2KDM4EALDH1A1NPSR1
SCHEMBL5199685 0.69 ALDH1A1 (0.46) HPGDSMN1; SMN2KDM4EALDH1A1LMNA
SCHEMBL27620887 0.69 EGFR (0.45) HPGDKDM4EALDH1A1POLBAGTR1
SCHEMBL8431590 0.69 PARP1 (0.44) HPGDKDM4EALDH1A1NPSR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1596864-A2 FLAVONE ACETIC ACID ANALOGS AND METHODS OF USE THEREOF UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2005-11-23 EP disclosed
US-20050171138-A1 Flavone acetic acid analogs and methods of use thereof LEE KUO-HSIUNG (US) 2005-08-04 US disclosed
US-6916831-B2 Flavone acetic acid analogs and methods of use thereof THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2005-07-12 US disclosed
WO-2004075858-A2 FLAVONE ACETIC ACID ANALOGS AND METHODS OF USE THEREOF UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2004-09-10 WO disclosed
US-20040167151-A1 Flavone acetic acid analogs and methods of use thereof NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2004-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171138-A1 Flavone acetic acid analogs and methods of use thereof HAO1, HAO2, AOX1 HPGD 1151/4885SMN1; SMN2 3753/4885KDM4E 2044/4885
US-20040167151-A1 Flavone acetic acid analogs and methods of use thereof HAO1, HAO2, AOX1 HPGD 787/4885SMN1; SMN2 3869/4885KDM4E 1454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.